1. Bunn, H.F. & Forget, B.G. Hemoglobin: molecular genetic and clinical aspects (W.B. Saunders Co, Philadelphia; 1986).
2. Winslow, R.M. Hemoglobin-based red cell substitutes. (Johns Hopkins University Press, Baltimore, 1992).
3. Chang, T.M.S. Blood substitutes: principles, methods, products, and clinical trials. Vol. 1. (ed. Chang, T.M.S.) (Karger-Lands System, New York, 1998).
4. Nelson, D. in Blood substitutes: principles, methods, products and clinical trials Vol. II (ed. Chang, T.M.S.) 39–57 (Karger-Landes System, New York; 1998).
5. D'Agnillo, F. & Alayash, A.I. Site specific modifications and toxicity of blood substitutes: the case of diaspirin cross-linked hemoglobin. Adv. Drug Deliv. Rev. (in press).